CEL SCI CORP CVM Cash Flow

Cel sci corp (CVM)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
-31,419	-28,855	-22,134	-32,213	-26,143	-24,403	-31,837	-21,904	-20,353	-24,072	-14,363	-10,497	-9,895	-10,324	-11,512	-20,245	-20,813	-24,514	-34,692	-32,038	-30,054	-30,863	-27,352	-21,844	-23,847	-11,195	-9,170	-10,037	-6,425	-14,206	-15,477	-15,228	-17,506	-23,042	-25,712	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
1,269	925	633	677	657	649	650	642	622	629	632	636	644	652	663	1,060	945	834	720	735	749	745	745	234	248	287	364	444	475	528	533	488	526	528	531	0	0	0
Share-based payments for services
691	772	856	869	884	727	530	430	278	196	232	284	392	501	751	747	737	705	565	598	650	746	694	624	644	538	454	488	438	543	527	478	324	215	214	0	0	0
Modification of warrants issued to consultants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	76	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Modification of warrants issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Equity based compensation
6,904	5,654	4,428	3,176	2,119	1,868	2,743	2,570	2,430	2,516	1,380	1,852	1,946	1,997	2,113	1,798	1,999	2,473	5,105	7,036	6,880	6,508	3,958	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
401(k) contributions paid in common stock
-	149	-	-	-	144	145	145	147	148	151	396	320	240	161	168	164	164	165	148	151	152	155	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Extension of options issued to employees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36	0	0	0	-	-	-	-
Modification of stock options and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Employee option cost
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,358	2,229	2,154	2,098	2,010	1,535	0	0	0
Common stock contributed to 401 (k) plan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	158	158	155	154	154	155	156	150	0	0	0
Impairment loss on abandonment of patents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12	22	18	34	47	44	46	30	16	9	0	0	0
Loss on retired equipment
-	-	-	-	-	-	-	-	-	-	1	-0	-0	-0	0	0	0	0	0	-0	-0	-0	0	0	0	2	4	4	9	10	9	14	7	4	2	0	0	0
(Loss)/gain on derivative instruments
0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Capitalized lease interest
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount
-	-	-	-	-	-	1,956	2,852	1,940	1,529	917	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capitalized lease interest
-	-	-	-	-	-	-168	-225	-216	-208	-200	-247	-240	-234	-227	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss (gain) on derivative instruments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
(Increase)/decrease in assets:
Receivables
50	74	55	198	186	305	99	-410	-126	-240	-129	186	-24	-11	-1	-87	-23	-154	-5	62	-112	94	-7	95	25	-87	84	-138	61	-6	298	-439	-270	-466	-457	0	0	0
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	782	-	705	642	580	544	557	571	585	598	612	623	616	629	0	0	0
Prepaid expenses
-309	-330	-137	264	270	262	153	304	328	244	151	8	7	-28	15	-619	-158	13	-68	52	-423	-501	-158	73	459	268	529	899	614	1,012	775	-3,315	-3,407	-3,408	-1,729	0	0	0
Supplies used for R&D and manufacturing
-185	-50	-137	181	185	92	27	642	623	622	336	184	169	137	393	-55	-171	208	50	-868	-724	-983	-435	516	674	450	367	236	81	233	186	1	110	195	-94	0	0	0
Deposits
-	-	-	-	-	-	150	150	150	154	154	150	150	145	145	150	150	150	150	150	150	150	-200	-200	-600	-600	-400	0	0	0	-	-	-	-	-	-	-	-
Increase/(decrease) in liabilities:
Accounts payable
-3,361	-3,742	-4,084	-4,121	-3,461	-2,962	-2,514	-2,054	664	5,208	5,420	4,204	3,484	-798	-2,389	1,045	1,779	1,857	3,981	1,676	338	86	-751	184	919	1,128	1,316	428	-288	-233	-168	-474	-212	-285	-788	0	0	0
Accrued expenses
-233	37	-170	-769	-614	-892	-731	-72	392	650	558	758	-138	-49	290	-255	149	-301	-458	60	-1	323	433	-34	449	311	101	389	40	8	-99	-2	-11,978	51	147	0	0	0
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1	1	-0	-1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Due to employees
-334	-110	-55	-481	-44	50	71	702	476	392	256	223	247	114	72	-86	-5	3	57	93	-16	55	-78	42	109	59	186	61	40	21	-2	20	-41	-25	-23	0	0	0
Other liabilities
-2	-8	-6	-2	0	1	4	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent liability
-	-	-	-	-	-	-	-	-	-	-	-	-4	-3	1	15	13	12	6	-7	-5	-4	-3	-2	-2	-1	-0	16	15	12	11	-5	-4	-2	-3	0	0	0
Deposits held
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	5	5	0	0	0	0
Net cash used in operating activities
-16,520	-16,264	-16,320	-16,678	-14,812	-14,934	-13,389	-12,586	-12,934	-12,165	-13,791	-17,214	-19,504	-21,483	-23,082	-21,562	-22,393	-24,232	-23,833	-24,221	-23,996	-22,450	-22,928	-20,603	-18,049	-16,470	-13,548	-13,411	-13,070	-12,573	-12,190	-13,751	-17,799	-18,732	-22,555	0	0	0
CASH FLOWS FROM INVESTING ACTIVITIES:
Decrease in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-21	0	0	0
Purchases of property and equipment
769	273	177	171	161	7	1	0	0	0	-	-	-	-	31	48	38	71	73	93	133	112	103	75	52	94	102	104	100	54	54	84	150	205	216	0	0	0
Proceeds from sale of equipment
-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Expenditures for patent costs
104	104	158	170	123	122	57	8	7	7	6	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	30	24	38	78	78	155	133	121	122	0	0	0
Net cash used in investing activities
-874	-373	-335	-341	-285	-129	-58	-9	-7	-17	-17	-8	-23	-19	-34	-63	-56	-91	-93	-104	-144	-147	-138	-115	-98	-125	-132	-129	-139	-133	-133	-240	-284	-305	-318	0	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock
12,917	5,050	0	4,700	4,665	9,367	11,792	10,443	11,797	9,234	10,519	11,730	15,011	14,579	21,420	16,727	27,000	25,292	21,148	21,278	15,548	15,454	28,428	28,410	19,266	19,361	9,788	9,807	14,930	20,286	14,289	18,225	11,696	7,746	3,936	0	0	0
Payments on oblgations under capital leases
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Payments of stock issuance costs
0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the purchase of stock by officers and directors
0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of warrants
13,281	14,164	14,517	18,936	12,718	10,062	9,412	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercises of options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Payments on obligations under finance lease
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,950	4,950	4,950	1,980	0	0	0	0
Payments on obligations under capital lease
-	-	-	-	-	-	6	6	5	4	3	3	5	8	8	8	8	8	8	8	8	7	8	8	8	8	6	0	0	0	-	-	-	-	-	-	-	-
Net cash provided by financing activities
26,210	19,339	14,791	24,158	17,549	19,603	21,388	13,710	14,474	11,939	13,260	13,236	15,005	13,467	20,308	15,614	25,887	25,284	21,139	21,270	16,150	18,565	31,538	31,519	21,767	19,353	9,781	9,802	14,927	19,980	12,004	10,638	5,611	1,646	565	0	0	0
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
8,815	2,701	-1,865	7,138	2,451	4,539	7,940	1,114	1,532	-243	-548	-3,986	-4,522	-8,035	-2,808	-6,011	3,437	961	-2,786	-3,055	-7,991	-4,032	8,472	10,801	3,619	2,757	-3,899	-3,738	1,717	7,274	-319	-3,353	-12,472	-17,391	-22,307	0	0	0
Decrease in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,760	6,706	6,706	4,546	2,146	0	0	0	0
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	0	0	0	0
Increase in common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Increase in common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-8	-8	-8	-8	0	0	0	0
Increase in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-241	-241	-241	-241	0	0	0	0
Decrease in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-250	-250	-250	-250	0	0	0	0
Increase in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Decrease in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	0	0	0	0
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Increase in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Decrease in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Increase in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-29	-16	-289	-53	0	0	0	-	-	-	-
Increase in prepaid services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-29	-16	-289	-53	0	0	0	-	-	-	-
Increase in patent costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35	32	15	22	-65	-6	-21	28	0	0	0
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Decrease in derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-202	0	0	0
Increase in additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-202	0	0	0
Increase additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Decrease in additional paid in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	325	0	0	0	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in additional paid in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Direct offering costs charged to APIC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Increase in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	0	0	0	-	0	0	0
Decrease additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Increase in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	-	0	0	0
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment included in current liabilities
0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capitalizable patent costs included in current liabilities
-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Finance lease obligation included in accounts payable
0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid consulting services paid with issuance of common stock
76	-12	22	-71	149	142	162	147	134	-2	-3	-21	-78	-8	18	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing costs included in current liabilities
-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment acquired through capital lease
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrants issued in connection with public offering
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	-	-	-	-
Increase in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0
Increase in research and office equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-45	-49	41	0	34	17	1	1	0	0	0
Decrease (increase) in capital lease obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	36	36	-36	0	0	0	0	-	-	-	-
Patent costs purchased with common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Lease payments included in accounts payable at year end
-	-	-	-	-	-	-	-	0	2	1	2	1	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes payable converted into common shares
-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
(Gain)/loss on derivative instruments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0
(Increase) in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of warrant liabilities on the date of issuance reclassed to liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-8,463	-8,463	-744	1,539	-5,320	-5,320	-5,037	-7,321	-4,200	-4,200	-6,360	-8,760	-6,706	-6,706	-4,546	-2,146	0	0	0	0
Increase in receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in research and office equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0
Decrease in capital lease obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	1	1	1	0	0	0	0	-	-	-	-
Financing costs included in accounts payable at year end
-	-	-	-	-	-	-	-	-	-	35	114	163	103	46	-103	1	21	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivable due under the litigation funding arrangement offset by the same amount payable to the legal firm providing the services
-	-	-	-	-	-	-	-	-	-	-305	247	311	244	305	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	-1	-1	0	0	0	0	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	-	-	-	-
Cash paid for interest
1,492	1,655	1,809	1,793	1,780	1,765	1,750	1,787	1,820	1,852	1,888	1,880	1,873	1,865	1,900	3,277	2,854	2,432	1,969	1,951	1,951	1,951	1,965	168	169	170	156	168	167	201	377	408	408	373	195	0	0	0